Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.

导出 OA

翻译打印收藏纠错

作者： Philip E,Castle ^[1] ; Rachael,Adcock ^[1] ; Jack,Cuzick ^[1] ; Nicolas,Wentzensen ^[1] ; Norah E,Torrez-Martinez ^[1] ; Salina M,Torres ^[1] ; Mark H,Stoler ^[1] ; Brigitte M,Ronnett ^[1] ; Nancy E,Joste ^[1] ; Teresa M,Darragh ^[1] ; Patti E,Gravitt ^[1] ; Mark,Schiffman ^[1] ; William C,Hunt ^[1] ; Walter K,Kinney ^[1] ; Cosette M,Wheeler ^[1] ; New Mexico HPV Pap Registry Steering Committee ; p16 IHC Study Panel

作者单位： From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney). ^[1]